Wiedemann B, Seeberg A
Infection. 1983 Nov-Dec;11(6):340-4. doi: 10.1007/BF01641361.
The in vitro activity of apalcillin was tested against 350 clinical isolates of Escherichia coli, Enterobacter, Klebsiella, Proteus, Pseudomonas aeruginosa and Streptococcus faecalis. Using a minimal inhibitory concentration of 16 mg/l as the breakpoint, only 19.7% of the strains were resistant to apalcillin. A regression analysis demonstrated that it is possible to test bacteria for sensitivity with a 20 micrograms apalcillin disc. The results on Mueller-Hinton agar are very similar to those on Iso-Sensitest medium. Like other ureido penicillins, apalcillin is sensitive to most beta-lactamases; it is effective against ampicillin-resistant strains since it penetrates the outer membrane of gram-negative bacteria well and is highly effective against target proteins. Strains producing high amounts of beta-lactamases do become resistant to apalcillin.
对阿帕西林的体外活性进行了测试,受试菌株包括350株临床分离的大肠杆菌、肠杆菌属、克雷伯菌属、变形杆菌属、铜绿假单胞菌和粪肠球菌。以16mg/l的最低抑菌浓度作为分界点,只有19.7%的菌株对阿帕西林耐药。回归分析表明,使用含20μg阿帕西林的药敏纸片可检测细菌的敏感性。在穆勒-欣顿琼脂上的结果与在异感测试培养基上的结果非常相似。与其他脲基青霉素一样,阿帕西林对大多数β-内酰胺酶敏感;它对耐氨苄西林菌株有效,因为它能很好地穿透革兰氏阴性菌的外膜,并且对靶蛋白高效。产生大量β-内酰胺酶的菌株确实会对阿帕西林耐药。